103 related articles for article (PubMed ID: 31610471)
1. Trichostatin A and vorinostat promote adipogenic differentiation through H3K9 acetylation and dimethylation.
Wang X; Wang Z; Wang Q; Liang H; Liu D
Res Vet Sci; 2019 Oct; 126():207-212. PubMed ID: 31610471
[TBL] [Abstract][Full Text] [Related]
2. Histone acetylation together with DNA demethylation empowers higher plasticity in adipocytes to differentiate into osteoblasts.
Cho YD; Kim BS; Kim WJ; Kim HJ; Baek JH; Woo KM; Seol YJ; Ku Y; Ryoo HM
Gene; 2020 Apr; 733():144274. PubMed ID: 31809844
[TBL] [Abstract][Full Text] [Related]
3. Short-chain fatty acids enhance adipocyte differentiation in the stromal vascular fraction of porcine adipose tissue.
Li G; Yao W; Jiang H
J Nutr; 2014 Dec; 144(12):1887-95. PubMed ID: 25320182
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Library Screen Identifies Abexinostat as Novel Regulator of Adipocytic and Osteoblastic Differentiation of Human Skeletal (Mesenchymal) Stem Cells.
Ali D; Hamam R; Alfayez M; Kassem M; Aldahmash A; Alajez NM
Stem Cells Transl Med; 2016 Aug; 5(8):1036-47. PubMed ID: 27194745
[TBL] [Abstract][Full Text] [Related]
5. The epigenetic modifiers 5-aza-2'-deoxycytidine and trichostatin A influence adipocyte differentiation in human mesenchymal stem cells.
Zych J; Stimamiglio MA; Senegaglia AC; Brofman PR; Dallagiovanna B; Goldenberg S; Correa A
Braz J Med Biol Res; 2013 May; 46(5):405-16. PubMed ID: 23797495
[TBL] [Abstract][Full Text] [Related]
6. Chemical and genetic blockade of HDACs enhances osteogenic differentiation of human adipose tissue-derived stem cells by oppositely affecting osteogenic and adipogenic transcription factors.
Maroni P; Brini AT; Arrigoni E; de Girolamo L; Niada S; Matteucci E; Bendinelli P; Desiderio MA
Biochem Biophys Res Commun; 2012 Nov; 428(2):271-7. PubMed ID: 23085045
[TBL] [Abstract][Full Text] [Related]
7. Low-level perfluorooctanoic acid enhances 3 T3-L1 preadipocyte differentiation via altering peroxisome proliferator activated receptor gamma expression and its promoter DNA methylation.
Ma Y; Yang J; Wan Y; Peng Y; Ding S; Li Y; Xu B; Chen X; Xia W; Ke Y; Xu S
J Appl Toxicol; 2018 Mar; 38(3):398-407. PubMed ID: 29094436
[TBL] [Abstract][Full Text] [Related]
8. Treatment of buffalo (Bubalus bubalis) donor cells with trichostatin A and 5-aza-2'-deoxycytidine alters their growth characteristics, gene expression and epigenetic status and improves the in vitro developmental competence, quality and epigenetic status of cloned embryos.
Saini M; Selokar NL; Agrawal H; Singla SK; Chauhan MS; Manik RS; Palta P
Reprod Fertil Dev; 2016 Apr; 28(6):824-37. PubMed ID: 25409339
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor trichostatin A promotes the osteogenic differentiation of rat adipose-derived stem cells by altering the epigenetic modifications on Runx2 promoter in a BMP signaling-dependent manner.
Hu X; Zhang X; Dai L; Zhu J; Jia Z; Wang W; Zhou C; Ao Y
Stem Cells Dev; 2013 Jan; 22(2):248-55. PubMed ID: 22873791
[TBL] [Abstract][Full Text] [Related]
10. A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutant.
Kim DW; Park JW; Willingham MC; Cheng SY
Hum Mol Genet; 2014 May; 23(10):2651-64. PubMed ID: 24381310
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical effects of the epigenetic modifiers 5-aza-deoxycytidine and suberoylanilide hydroxamic acid on adipogenesis.
El-Serafi AT; Sandeep D; Abdallah S; Lozansson Y; Hamad M; Khan AA
Differentiation; 2019; 106():1-8. PubMed ID: 30818187
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of class I HDACs imprints adipogenesis toward oxidative and brown-like phenotype.
Ferrari A; Longo R; Peri C; Coppi L; Caruso D; Mai A; Mitro N; De Fabiani E; Crestani M
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Apr; 1865(4):158594. PubMed ID: 31904421
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modifications of the Zfp/ZNF423 gene control murine adipogenic commitment and are dysregulated in human hypertrophic obesity.
Longo M; Raciti GA; Zatterale F; Parrillo L; Desiderio A; Spinelli R; Hammarstedt A; Hedjazifar S; Hoffmann JM; Nigro C; Mirra P; Fiory F; Formisano P; Miele C; Smith U; Beguinot F
Diabetologia; 2018 Feb; 61(2):369-380. PubMed ID: 29067487
[TBL] [Abstract][Full Text] [Related]
14. Vorinostat, SAHA, represses telomerase activity via epigenetic regulation of telomerase reverse transcriptase in non-small cell lung cancer cells.
Li CT; Hsiao YM; Wu TC; Lin YW; Yeh KT; Ko JL
J Cell Biochem; 2011 Oct; 112(10):3044-53. PubMed ID: 21678477
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation and histone modifications affect the expression of the exogenous DsRed gene in transgenic goats.
Nuo MT; Yuan JL; Yang WL; Gao XY; He N; Liang H; Cang M; Liu DJ
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706651
[TBL] [Abstract][Full Text] [Related]
16. Regulation of adipocyte differentiation by histone deacetylase inhibitors.
Kim SN; Choi HY; Kim YK
Arch Pharm Res; 2009 Apr; 32(4):535-41. PubMed ID: 19407971
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic mechanisms are involved in the regulation of ethanol consumption in mice.
Qiang M; Li JG; Denny AD; Yao JM; Lieu M; Zhang K; Carreon S
Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25522411
[TBL] [Abstract][Full Text] [Related]
18. CACUL1 reciprocally regulates SIRT1 and LSD1 to repress PPARγ and inhibit adipogenesis.
Jang MJ; Park UH; Kim JW; Choi H; Um SJ; Kim EJ
Cell Death Dis; 2017 Dec; 8(12):3201. PubMed ID: 29233982
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells.
Nordström L; Andersson E; Kuci V; Gustavsson E; Holm K; Ringnér M; Guldberg P; Ek S
BMC Cancer; 2015 Apr; 15():273. PubMed ID: 25880212
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Activity of Peroxisome Proliferator-Activated Receptor Gamma Agonists Increases the Anticancer Effect of Histone Deacetylase Inhibitors on Multiple Myeloma Cells.
Aouali N; Broukou A; Bosseler M; Keunen O; Schlesser V; Janji B; Palissot V; Stordeur P; Berchem G
PLoS One; 2015; 10(6):e0130339. PubMed ID: 26091518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
